About Metropolis

Metropolis top pathology lab in India

We are one of the leading diagnostics companies in India, by revenue, as of March 31, 2018 (Source: Frost & Sullivan). We have widespread presence across 18 states in India, as of March 31, 2018, with leadership position in west and south India (Source: Frost & Sullivan). Through our widespread operational network, we offer a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease. We also offer analytical and support services to clinical research organizations for their clinical research projects. During the financial year 2018, we conducted approximately 16.0 million tests from approximately 7.7 million patient visits.

We offer a broad range of approximately 3,480 clinical laboratory tests and 524 profiles, as of March 31, 2018. The profile comprises of a variety of test combinations which are specific to a disease or disorder as well as wellness profiles that are used for health and fitness screening.

We conduct our operations through our laboratory and service network. As of March 31, 2018, our laboratory network consists of 106 clinical laboratories and our service network comprises 1,130 patient touch points (out of which 28 are located outside India).

  • Corporate Overview

    We are one of the leading diagnostics companies in India, by revenue, as of March 31, 2018 (Source: Frost & Sullivan). We have widespread presence across 18 states in India, as of March 31, 2018, with leadership position in west and south India (Source: Frost & Sullivan).
    Read More
  • Management Team

    we have 4,585 full-time employees, including 183 pathologists and doctors and 2,022 scientific officers and phlebotomists located in India, and 222 full-time employees located outside India. Our laboratories are managed by qualified scientific staff and supervised by a team of pathologists with specializations in relevant fields of laboratory medicine. !

    Read More
  • Our Subsidiaries

    Metropolis has established track record of successful acquisition and integration in India and overseas; Click to check our list of Subsidiaries

    Read More
  • Board of Directors

    Dr Sushil Shah: Founder and Chairman

    Ms. Ameera Shah: Managing Director

    Mr. Milind Shripad Sarwate, Independent Director

    Dr Vivek Gambhir, Independent Director

    Mr. Mihir Doshi, Independent Director

    Mr. Sanjay Bhatnagar, Independent Director
    Read More
  • Awards & Accolades

    Check out our list of awards and accolades


    Read More
  • Milestones

    Our story started back in 1981, in Mumbai, the bustling business capital of India. Laboratory medicine was in its infancy in the country of one billion but one laboratory was already making the news with its penchant for technology and quality. One laboratory was constantly re-setting the bar for innovation: Metropolis!

    Read more on our 3 decade glorious journey!

    Read More
  • Corporate Social Responsibility

    Giving back to the society is embedded in the value system of Metropolis and we believe and aim to bring about a positive change in the nation. For the past 3 decades, Metropolis has been at the forefront in conducting impactful camps and driving numerous workshops for different sections of the society.

    Read our CSR policy here!

    Read More
  • Logistics and Procedures

    Logistics and Specimen Tracking 

    We believe that an efficient logistics network is critical to maintain quality of specimens collected by us.! Click to read our Logistics Capabilities and Procedures

    Read More
  • Information Technology

    Our information technology systems help serve our patients, ensure efficiency in and improve productivity of our operations as well as help in monitoring our network’s performance, refining resource allocation, tracking consumption patterns and proactively directing patients to certain locations and services.
    Read More
  • Material Creditors

    Read More